Ardian arranges a senior financing for Telemos Capital and Medeuropa's acquisition of CCO Perpignan

MedEuropa is a European cancer care company with a strong focus on radiotherapy. Radiotherapy is one of the most commonly used therapies for cancer treatment and consists in the use of high doses of radiation to eliminate cancer cells and shrink tumors. It can be used as a standalone oncology treatment or in combination with other cancer treatments such as surgery or chemotherapy. 

Headquartered in Switzerland, the MedEuropa platform was founded in 2017 by Telemos Capital. The network was initially created through the acquisition of two radiotherapy centers in Germany in January 2019 (Krefeld and Hannover, the leading providers of Gamma Knife treatments, a specialized application of radiotherapy for complex brain tumors) and is to be further enlarged through the acquisition of CCO Perpignan, a radiotherapy center in the South of France. 

The combination of all three entities will form a Group operating a total of six treatment machines treating a total c. 2,900 patients per year. As has been the case with the German acquisitions, MedEuropa will continue to partner with the CCO Perpignan doctors, ensuring continuity of high-quality care for patients and referring physicians.
 
Guillaume Chinardet, Head of Ardian Private Debt France, said: “We look forward to the long term cooperation with the MedEuropa management team and Telemos Capital, valuable partners with strong expertise in the European healthcare services market. We are convinced that MedEuropa will achieve further growth via strategic acquisitions in the fragmented European radiotherapy market.”

Jean-David Ponsin, Managing Director at Ardian Private Debt, further added:”We are pleased to support the Group in this new chapter of its growth journey and we are convinced that our financing solution will provide the Group with the flexibility to pursue its future development.”

Ralph Hefti, MedEuropa’s CEO, commented: “Ardian's ability to offer a flexible solution to the Group's requirements was key to this partnership. Ardian has been extremely responsive and creative and has set up financing that is perfectly suited to the way MedEuropa intends to move forward.”

Nils Hagerstål, Vice President at Telemos Capital concluded:”MedEuropa is actively considering further acquisition opportunities in the radiotherapy market, with the aim of building a platform in Western Europe. This ambitious development strategy demands a solid yet flexible financing solution, which Ardian has successfully provided.”